LTX-001

N/A

Report date: 2024/11/12 10:42:49
NME

Base Information

Drug NameLTX-001
Drug Alias NameLTX-001
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlutaminase kidney isoform, mitochondrial modulators
TargetsGlutaminase kidney isoform, mitochondrial
Therapy Area/IndicationsSchizophreniaDepressive Disorder, MajorAmyotrophic Lateral Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusIND
Highest Status in ChinaN/A
Originator CompaniesLeal Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesLeal Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsSchizophreniaDepressive Disorder, MajorAmyotrophic Lateral Sclerosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A